| Shanghai Pharmaceuticals Co Ltd, China's second largest pharmaceutical products distributor, has secured four cornerstone investors for its $1.2 billion Hong Kong IPO.
Temasek Holdings is expected to invest $300 million, Malaysian conglomerate Guoco Group Ltd plans to spend $150 million, while Pfizer Inc and Bank of China Group Investment each plan to invest $50 million in the IPO, the newspaper reported, citing a person familiar with the matter..............................................Full Article: Source
|